Anthropometric Measurements as Predictors of Low Birth Weight Among Tanzanian Neonates: A Hospital-Based Study
November 7, 2025
Free CME credits
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
Brand Name :
lysteda
Synonyms :
Tranhexamic acid, trans AMCHA
Class :
Antifibrinolytic agents
Brand Name :
lysteda
Synonyms :
Tranhexamic acid, trans AMCHA
Class :
Antifibrinolytic agents
Dosage Forms & Strengths
Tablet
650mg
Orally
thrice a day
1300mg orally thrice a day until five days during menstruation
1000-1500mg every 8-12hours until 12 days of postop
1000-1500mg every 8-12hours until ten days
1000-1500mg every 8-12hours until seven days
1000-1500mg orally twice a day/thrice a day
Refer adult dosing
may enhance the effects of the other by pharmacodynamic synergism
may increase the toxicity of each other through pharmacodynamic synergism
may increase the toxicity of each other through pharmacodynamic synergism
may diminish the serum concentration of CYP3A4 substrates
tranexamic acid: they may increase the thrombogenic effect of hormonal contraceptives
tranexamic acid: they may increase the thrombogenic effect of hormonal contraceptives
tranexamic acid: they may increase the thrombogenic effect of hormonal contraceptives
tranexamic acid: they may increase the thrombogenic effect of hormonal contraceptives
Hormonal Contraceptives increase the effect of thrombogenesis of tranexamic acid
Hormonal Contraceptives increase the effect of thrombogenesis of tranexamic acid
Hormonal Contraceptives increase the effect of thrombogenesis of tranexamic acid
Hormonal Contraceptives increase the effect of thrombogenesis of tranexamic acid
Hormonal Contraceptives increase the effect of thrombogenesis of tranexamic acid
Hormonal Contraceptives increase the effect of thrombogenesis of tranexamic acid
estrogens esterified/methyltestosterone
may increase the thrombogenic effect of estrogen derivatives
may decrease the effect of each other through pharmacodynamic antagonism
may decrease the effect of each other through pharmacodynamic antagonism
may decrease the effect of each other through pharmacodynamic antagonism
Frequency defined:
>10%
Abdominal pain
Headache
Musculoskeletal pain
Nasal and sinus symptoms
Back pain
1-10%
Arthralgia
Fatigue
Muscle cramps and spasms
Anemia
Post-marketing reports
Allergic reactions
Nausea
Anaphylactic shock
Vomiting
Dizziness
Pregnancy consideration: Insufficient data available
Lactation: Excretion of the drug in human breast milk is unknown
Pregnancy category:
Patient information leaflet
Generic Name: tranexamic acid
Pronounced: tran-ex-AM-ik-AS-id
Why do we use tranexamic acid?
It is an antifibrinolytic that is used to decrease or prevent hemorrhagic episodes, particularly in hyperfibrinolytic illnesses.
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
On course completion, you will receive a full-sized presentation quality digital certificate.
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.
When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
